These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 29891025)

  • 1. Clinical Outcomes of Aspirin Interaction with Other Non-Steroidal Anti-Inflammatory Drugs: A Systematic Review.
    Alqahtani Z; Jamali F
    J Pharm Pharm Sci; 2018; 21(1s):29854. PubMed ID: 29891025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled study on the influence of acetaminophen, diclofenac, or naproxen on aspirin-induced inhibition of platelet aggregation.
    Galliard-Grigioni KS; Reinhart WH
    Eur J Pharmacol; 2009 May; 609(1-3):96-9. PubMed ID: 19272375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects.
    Capone ML; Sciulli MG; Tacconelli S; Grana M; Ricciotti E; Renda G; Di Gregorio P; Merciaro G; Patrignani P
    J Am Coll Cardiol; 2005 Apr; 45(8):1295-301. PubMed ID: 15837265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
    Weir MR; Sperling RS; Reicin A; Gertz BJ
    Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
    Catella-Lawson F; Reilly MP; Kapoor SC; Cucchiara AJ; DeMarco S; Tournier B; Vyas SN; FitzGerald GA
    N Engl J Med; 2001 Dec; 345(25):1809-17. PubMed ID: 11752357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin.
    Kimmel SE; Berlin JA; Reilly M; Jaskowiak J; Kishel L; Chittams J; Strom BL
    J Am Coll Cardiol; 2004 Mar; 43(6):985-90. PubMed ID: 15028354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of non-steroidal anti-inflammatory drugs on antiplatelet effect of aspirin.
    Yokoyama H; Ito N; Soeda S; Ozaki M; Suzuki Y; Watanabe M; Kashiwakura E; Kawada T; Ikeda N; Tokuoka K; Kitagawa Y; Yamada Y
    J Clin Pharm Ther; 2013 Feb; 38(1):12-5. PubMed ID: 22882748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis.
    Gengo FM; Rubin L; Robson M; Rainka M; Gengo MF; Mager DE; Bates V
    J Clin Pharmacol; 2008 Jan; 48(1):117-22. PubMed ID: 18094224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of common nonsteroidal anti-inflammatory medications by whole blood aggregometry: a clinical evaluation for the perioperative setting.
    Scott WW; Levy M; Rickert KL; Madden CJ; Beshay JE; Sarode R
    World Neurosurg; 2014 Nov; 82(5):e633-8. PubMed ID: 24698769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study.
    Ray WA; Stein CM; Hall K; Daugherty JR; Griffin MR
    Lancet; 2002 Jan; 359(9301):118-23. PubMed ID: 11809254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of combinations of acetylsalicylic acid, acetaminophen, and diclofenac on platelet aggregation.
    Galliard-Grigioni KS; Fehr M; Reinhart WH
    Eur J Pharmacol; 2008 Oct; 595(1-3):65-8. PubMed ID: 18700139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of the combination of aspirin with non-steroidal anti-inflammatory drugs].
    Ito N; Yokoyama H; Soeda S; Suzuki Y; Ikeda N; Tokuoka K; Watanabe M; Kitagawa Y; Yamada Y
    Yakugaku Zasshi; 2011; 131(7):1073-7. PubMed ID: 21720137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies.
    McGettigan P; Henry D
    PLoS Med; 2011 Sep; 8(9):e1001098. PubMed ID: 21980265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications.
    Velentgas P; West W; Cannuscio CC; Watson DJ; Walker AM
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):641-52. PubMed ID: 16392153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.
    Renda G; Tacconelli S; Capone ML; Sacchetta D; Santarelli F; Sciulli MG; Zimarino M; Grana M; D'Amelio E; Zurro M; Price TS; Patrono C; De Caterina R; Patrignani P
    Clin Pharmacol Ther; 2006 Sep; 80(3):264-74. PubMed ID: 16952493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets.
    Saxena A; Balaramnavar VM; Hohlfeld T; Saxena AK
    Eur J Pharmacol; 2013 Dec; 721(1-3):215-24. PubMed ID: 24075938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review.
    Asghar W; Jamali F
    Inflammopharmacology; 2015 Feb; 23(1):1-16. PubMed ID: 25515365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and Multidrug Resistance Protein 4 expression in human platelets.
    Temperilli F; Di Franco M; Massimi I; Guarino ML; Guzzo MP; Valesini G; Frati L; Pulcinelli FM
    Vascul Pharmacol; 2016 Jan; 76():11-7. PubMed ID: 26141932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs.
    Li X; Fries S; Li R; Lawson JA; Propert KJ; Diamond SL; Blair IA; FitzGerald GA; Grosser T
    Proc Natl Acad Sci U S A; 2014 Nov; 111(47):16830-5. PubMed ID: 25385584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib.
    Konstam MA; Weir MR; Reicin A; Shapiro D; Sperling RS; Barr E; Gertz BJ
    Circulation; 2001 Nov; 104(19):2280-8. PubMed ID: 11696466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.